RxDoctor Payments DataLook up a doctor →

Lance Rudolph, MD

Internal Medicine · Albuquerque, NMNPI 1376502997

Payments from drug & device makers

$979,664in general payments, 2019–2025

Across 446 payments — averaging $2196.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$444K
  • Bristol Myers Squibb$241K
  • Bayer$75K
  • Ironwood Pharmaceuticals, Inc$46K
  • E.r. Squibb & Sons, L.L.C.$45K
  • Sanofi US Services Inc.$42K
  • plus $86K from 26 others
$38,982in research payments, 2019–2025

Across 14 payments — averaging $2784.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biocon Biologics Inc$39K
  • Eli Lilly$479

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$979,664 in reported general payments places this provider in the 95th percentile of 578 internal medicine providers in New Mexico.

See all internal medicine providers in New Mexico

Medicare billing

Part B allowed, 2024
$1,268,436
Medicare patients
1,119
Services billed
55,251

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →